Quick Facts
FONT-SIZE Plus   Neg
Share SHARE
mail  E-MAIL

Bovie Medical Reveals That J-Plasma Performs Well In All Surgeries

RELATED NEWS
Trade BVX now with 
7/10/2012 7:53 AM ET

Bovie Medical Corporation (BVX: Quote) Tuesday announced that its product J-Plasma has been performing well in both laparoscopic surgeries as well as open surgeries.

The company, engaged in the manufacture and marketing of electrosurgical products, stated that in multiple patient procedures, there was a decrease in smoke, less charring and overall excellent tissue response when compared to current electrosurgery devices.

Jeff Rencher, Vice President of Sales and Marketing of Surgical Products stated, "The positive results achieved by J-Plasma met all expectations as we prepare to embark on an aggressive marketing program for the product."

Click here to receive FREE breaking news email alerts for Bovie Medical Corp and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Starbucks Corp. said Thursday after the markets closed that its second quarter profit rose 9.4% from last year, helped by higher revenue. The company's quarterly earnings per share came in line with analysts' expectations, but its quarterly revenue fell short of analysts' forecast. The world's largest specialty coffee retailer also raised its full year earnings outlook. Software giant Microsoft Corp. said Thursday after the markets closed that its third quarter profit fell 6.6% from last year, when results were boosted by special upgrade offer revenues. However, the company's quarterly earnings per share came in above analysts' expectations as did its quarterly revenue. Apple Inc. said Wednesday after the markets closed that its second quarter profit rose 7% from last year, as sales surged and margins improved amid strong sales of its iPhones. The company's quarterly earnings per share also came in above analysts' expectations as did its quarterly revenue. At the same time, the company gave a slightly downbeat revenue forecast for the current quarter.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.